GENE - Genetic Technologies Limited

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 528.11M
Enterprise Value 325.8M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)25.40
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.90
52-Week Change 38.82%
S&P500 52-Week Change 321.60%
52 Week High 36.3200
52 Week Low 31.5600
50-Day Moving Average 33.7215
200-Day Moving Average 32.4152

Share Statistics

Avg Vol (3 month) 3585.71k
Avg Vol (10 day) 359.14k
Shares Outstanding 56.77M
Float 5.51M
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short (Jan 30, 2020) 4609.86k
Short Ratio (Jan 30, 2020) 40.19
Short % of Float (Jan 30, 2020) 4N/A
Short % of Shares Outstanding (Jan 30, 2020) 44.30%
Shares Short (prior month Dec 30, 2019) 4114.69k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Aug 14, 2019

Financial Highlights

Currency in AUD.

Fiscal Year

Fiscal Year Ends Jun 29, 2019
Most Recent Quarter (mrq)Jun 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-93.02%
Return on Equity (ttm)-198.23%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)-92.30%
Gross Profit (ttm)-250.82k
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-0.3000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.14
Book Value Per Share (mrq)0.15

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A